Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Fraser of Allander Institute : Economic Commentary [December 2016]

Fraser of Allander Institute (2016) Fraser of Allander Institute : Economic Commentary [December 2016]. [Report]

[img]
Preview
Text (FAI-2016-40-3-Fraser-of-Allander-Economic-Commentary)
FAI_2016_40_3_Fraser_of_Allander_Economic_Commentary.pdf
Final Published Version

Download (1MB)| Preview

    Abstract

    The Scottish economy returned to growth during the second quarter of 2016, and most indicators suggest that growth has continued – albeit at a relatively slow pace – through the remainder of the year. Employment in Scotland remains close to record levels. However, Scotland continues to lag the UK with Scotland’s recent growth rate just 1/3 of that in the UK. We expect Scotland to have grown by around 1% this year, broadly in line with our July forecast . Whilst unemployment has fallen sharply recently, this appears to stem, not from people finding work, but from people exiting the labour force.